AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$427M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$343M |
| 3 |
Booking.com
BKNG
|
+$325M |
| 4 |
Honeywell
HON
|
+$322M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$758M |
| 2 |
CERN
Cerner Corp
CERN
|
+$299M |
| 3 |
Altria Group
MO
|
+$282M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$274M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Technology | 15.1% |
| 3 | Healthcare | 13.46% |
| 4 | Consumer Discretionary | 11.57% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
AMES National
ATLO
$271M
| $475K | ﹤0.01% |
15,410
| – | – |
|
|
TAST
2627
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $474K | ﹤0.01% |
31,900
-5,100
| -14% | -$61.6K |
|
2628
Inovio Pharmaceuticals
INO
$84.7M
| $473K | ﹤0.01% |
10,050
+1,417
| +16% | +$78.2K |
|
2629
TFS Financial
TFSL
$5.18B
| $472K | ﹤0.01% |
29,916
-1,800
| -6% | -$27.8K |
|
2630
Cytokinetics
CYTK
$10.8B
| $470K | ﹤0.01% |
56,600
+13,500
| +31% | +$112K |
|
2631
NVE Corp
NVEC
$564M
| $470K | ﹤0.01% |
3,857
| – | – |
|
|
BFX
2632
DELISTED
BowFlex Inc.
BFX
| $468K | ﹤0.01% |
29,800
-100
| -0.3% | -$1.52K |
|
|
PTE
2633
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $468K | ﹤0.01% |
+796
| New | +$473K |
|
2634
Clear Channel Outdoor Holdings
CCO
$1.23B
| $466K | ﹤0.01% |
108,300
-5,250
| -5% | -$24.6K |
|
|
MRLN
2635
DELISTED
Marlin Business Services Corp
MRLN
| $466K | ﹤0.01% |
15,600
-200
| -1% | -$5.88K |
|
2636
Voyager Therapeutics
VYGR
$184M
| $465K | ﹤0.01% |
23,800
+8,000
| +51% | +$158K |
|
|
AAIC
2637
DELISTED
Arlington Asset Investment Corp.
AAIC
| $462K | ﹤0.01% |
44,800
+20,800
| +87% | +$232K |
|
2638
CNB Financial Corp
CCNE
$1.05B
| $461K | ﹤0.01% |
15,340
+200
| +1% | +$6K |
|
2639
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.35B
| $461K | ﹤0.01% |
35,399
-627
| -2% | -$8.1K |
|
|
ESND
2640
DELISTED
Essendant Inc.
ESND
| $459K | ﹤0.01% |
34,692
-3,990
| -10% | -$45.1K |
|
|
ANCB
2641
DELISTED
Anchor Bancorp
ANCB
| $459K | ﹤0.01% |
17,541
-10,857
| -38% | -$276K |
|
2642
Sonida Senior Living
SNDA
$2.04B
| $458K | ﹤0.01% |
2,860
+280
| +11% | +$46.2K |
|
|
STML
2643
DELISTED
Stemline Therapeutics, Inc.
STML
| $457K | ﹤0.01% |
28,500
+5,000
| +21% | +$89.3K |
|
|
TRQ
2644
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $455K | ﹤0.01% |
16,011
+5,811
| +57% | +$170K |
|
|
VRN
2645
DELISTED
Veren
VRN
| $454K | ﹤0.01% |
61,834
+2,291
| +4% | +$18K |
|
2646
FRP Holdings
FRPH
$448M
| $453K | ﹤0.01% |
14,000
+1,400
| +11% | +$41K |
|
|
TSC
2647
DELISTED
TriState Capital Holdings, Inc.
TSC
| $452K | ﹤0.01% |
17,300
+600
| +4% | +$15.2K |
|
2648
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.93B
| $451K | ﹤0.01% |
5,566
-50
| -0.9% | -$4K |
|
2649
Weis Markets
WMK
$1.9B
| $451K | ﹤0.01% |
8,451
+3,100
| +58% | +$153K |
|
|
PRTK
2650
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $451K | ﹤0.01% |
44,200
+10,400
| +31% | +$118K |
|
Similar funds
AllianceBernstein's Q2 2018 Portfolio in Review
As of Q2 2018, AllianceBernstein held 3,224 positions worth $144B, up 3.9% from $138B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
AllianceBernstein's Q2 2018 filing shows 203 new, 1,580 increased, 1,142 reduced and 118 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,991,062 shares worth $213M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $758M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q2 2018 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,991,062 shares worth $213M.
- AllianceBernstein added most to Verizon in Q2 2018, an estimated $427M increase.
- AllianceBernstein's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $758M.
- AllianceBernstein fully exited Time Warner Inc in Q2 2018, selling an estimated $274M.
- AllianceBernstein's ten largest holdings make up 17% of its $144B portfolio in Q2 2018.
- AllianceBernstein opened 203 new positions and closed 118 in Q2 2018.
- AllianceBernstein's portfolio value rose 3.9% quarter-over-quarter to $144B.
Based on AllianceBernstein's 13F filing for Q2 2018, filed 13 Aug 2018.